Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Previous studies have reported that telomere length in peripheral blood leukocytes can predict the clinical outcome of several cancers. However, whether leukocyte telomere length is associated with the prognosis of hepatocellular carcinoma (HCC) remains to be determined. In this study, relative telomere length (RTL) in peripheral blood leukocytes was measured using a real-time PCR-based method for 269 HCC patients treated with transarterial chemoembolization (TACE) from two independent hospitals. The association between RTL and the overall survival (OS) of HCC was analyzed. The immunological function of the HCC patients with different leukocyte RTLs was evaluated. Multivariate analyses indicated that long leukocyte RTL was significantly associated with poor OS of HCC patients, with a hazard ratio of 2.04 (95% confidence interval, 1.46-2.86; P < 0.001). Kaplan-Meier analyses showed a significant difference of median survival time between patients with long and short RTL (log rank P < 0.001). Fluorescence-activated cell sorting analyses showed that the long RTL group had a significantly increased percentage of CD4(+)CD25(+)FOXP3(+) Treg in CD4(+) T cells compared with short RTL group (P = 0.002). In conclusion, our results suggest that leukocyte RTL may serve as an independent prognostic marker for HCC patients treated with TACE.
Department of Cell Biology and Cell Engineering Research Center, State Key Laboratory of Cancer Biology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Han-Qiang
HQ
Liu
Jia-Ze
JZ
An
Juan
J
Liu
Ye-Fa
YF
Yang
Hong-Xin
HX
Zhang
Bin-Yu
BY
Zhao
Ji-Bin
JB
Li
Hu-Shan
HS
Yang
Zhi-Nan
ZN
Chen
Jin-Liang
JL
Xing
D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000235:genetics / Q000401:mortality* / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000379:methods; D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000378:metabolism / Q000648:ultrastructure*; D008113:Liver Neoplasms / Q000097:blood* / Q000235:genetics / Q000401:mortality* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D060888:Real-Time Polymerase Chain Reaction; D015996:Survival Rate; D013601:T-Lymphocytes / Q000378:metabolism; D016615:Telomere / Q000235:genetics* / Q000378:metabolism*